The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stock, A. T.
Right arrow Articles by Carbone, F. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stock, A. T.
Right arrow Articles by Carbone, F. R.
The Journal of Immunology, 2004, 173: 2241-2244.
Copyright © 2004 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: Prolonged Antigen Presentation after Herpes Simplex Virus-1 Skin Infection1

Angus T. Stock*, Scott N. Mueller*,{ddagger}, Allison L. van Lint*,{ddagger}, William R. Heath{dagger} and Francis R. Carbone2,*

* Department of Microbiology and Immunology, University of Melbourne, and {dagger} Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia; and {ddagger} Cooperative Research Centre for Vaccine Technology, Brisbane, Queensland, Australia

It has been reported that MHC class I-restricted Ag presentation persists for only a short period following infection with certain pathogens, declining in parallel with the emergence of specific CTL activity. We have examined this issue in the case of murine infection with HSV-1. We found that the period of Ag presentation capable of priming naive CD8+ T cells is comparatively prolonged, persisting for at least 7 days after infection, and continuing despite the appearance of localized CTL activity. Ag presentation was abbreviated to 3 or 4 days postinfection by surgical excision of the inoculation site early after infection. This intervention attenuated the size of the primary CTL response, implying that prolonged presentation is necessary to drive maximal CTL expansion. Combined, these data show that, in some types of infection, CTL priming can extend well beyond the first 24–48 h after primary inoculation.




This article has been cited by other articles:


Home page
J. Virol.Home page
J. D. Finn, J. Bassett, J. B. Millar, N. Grinshtein, T. C. Yang, R. Parsons, C. Evelegh, Y. Wan, R. J. Parks, and J. L. Bramson
Persistence of Transgene Expression Influences CD8+ T-Cell Expansion and Maintenance following Immunization with Recombinant Adenovirus
J. Virol., December 1, 2009; 83(23): 12027 - 12036.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Elnekave, M. Bivas-Benita, G. O. Gillard, P. Sircar, and A.-H. Hovav
A Matter of Timing: Unsynchronized Antigen Expression and Antigen Presentation Diminish Secondary T Cell Responses
J. Immunol., July 15, 2009; 183(2): 1013 - 1021.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. D. H. Lay, L. Zhang, R. M. Ribeiro, S. N. Mueller, G. T. Belz, and M. P. Davenport
Kinetics of Major Histocompatibility Class I Antigen Presentation in Acute Infection
J. Immunol., January 15, 2009; 182(2): 902 - 911.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Tzelepis, B. C. G. de Alencar, M. L. O. Penido, C. Claser, A. V. Machado, O. Bruna-Romero, R. T. Gazzinelli, and M. M. Rodrigues
Infection with Trypanosoma cruzi Restricts the Repertoire of Parasite-Specific CD8+ T Cells Leading to Immunodominance
J. Immunol., February 1, 2008; 180(3): 1737 - 1748.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A.-H. Hovav, M. W. Panas, S. Rahman, P. Sircar, G. Gillard, M. J. Cayabyab, and N. L. Letvin
Duration of Antigen Expression In Vivo following DNA Immunization Modifies the Magnitude, Contraction, and Secondary Responses of CD8+ T Lymphocytes
J. Immunol., November 15, 2007; 179(10): 6725 - 6733.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. E. Matthews, J. S. Qin, J. Yang, I. F. Hermans, M. J. Palmowski, V. Cerundolo, and F. Ronchese
Increasing the Survival of Dendritic Cells In Vivo Does Not Replace the Requirement for CD4+ T Cell Help during Primary CD8+ T Cell Responses
J. Immunol., November 1, 2007; 179(9): 5738 - 5747.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. T. Belz, L. Zhang, M. D. H. Lay, F. Kupresanin, and M. P. Davenport
Killer T cells regulate antigen presentation for early expansion of memory, but not naive, CD8+ T cell
PNAS, April 10, 2007; 104(15): 6341 - 6346.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. N. Mueller, C. M. Jones, A. T. Stock, M. Suter, W. R. Heath, and F. R. Carbone
CD4+ T Cells Can Protect APC from CTL-Mediated Elimination.
J. Immunol., June 15, 2006; 176(12): 7379 - 7384.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
B. B. Porter and J. T. Harty
The Onset of CD8+-T-Cell Contraction Is Influenced by the Peak of Listeria monocytogenes Infection and Antigen Display
Infect. Immun., March 1, 2006; 74(3): 1528 - 1536.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T.-C. Yang, J. Millar, T. Groves, N. Grinshtein, R. Parsons, S. Takenaka, Y. Wan, and J. L. Bramson
The CD8+ T Cell Population Elicited by Recombinant Adenovirus Displays a Novel Partially Exhausted Phenotype Associated with Prolonged Antigen Presentation That Nonetheless Provides Long-Term Immunity
J. Immunol., January 1, 2006; 176(1): 200 - 210.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Ploss, I. Leiner, and E. G. Pamer
Distinct Regulation of H2-M3-Restricted Memory T Cell Responses in Lymph Node and Spleen
J. Immunol., November 1, 2005; 175(9): 5998 - 6005.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. He, J. Zhang, Z. Mi, P. Robbins, and L. D. Falo Jr
Immunization with Lentiviral Vector-Transduced Dendritic Cells Induces Strong and Long-Lasting T Cell Responses and Therapeutic Immunity
J. Immunol., March 15, 2005; 174(6): 3808 - 3817.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.